A likely explanation for this biological phenomenon is the increase of CML cancer cells’ demand for DKC1 due to its role in post-transcriptional modification of rRNA necessary for the maintenance of an effective process of translation (Ge et al. 2010; Jack et al. 2011). This evidence concerns the gene DKC1 and chronic myelogenous leukemia, BCR-ABL1 positive.